Stocks · Health care · Pharmaceutical Preparations

ROCKET PHARMACEUTICALS, INC.

RCKT Clue Score36
United States Fiscal year ends December CIK 0001281895 Results filed 10 Aug 2026

What the insiders did Balanced

Insider
Date
Role
Action
Shares
Price
Amount
Rtw Investments, LP
19 Sep 2025
Director
Exercised, kept indirect
59,000
$17.81
$1.05M
Rtw Investments, LP
19 Sep 2025
Director
Exercised, kept indirect
41,000
$19.09
$782.76K
Rtw Investments, LP
19 Sep 2025
Director
Exercised, kept indirect
1,000,000
$40.03
$40.03M
Gaurav Shah
31 Mar 2021
CEO
Exercised, kept
75,880
$1.69
$128.24K
Kinnari Patel
24 Mar 2021
Chief Operating Officer
Exercised, kept
38,093
$1.69
$64.38K
Kinnari Patel
24 Mar 2021
Chief Operating Officer
Exercised, kept
55,869
$1.21
$67.60K
Jonathan David Schwartz
1 Feb 2021
Chief Medical Officer
Exercised, kept
213,101
$1.21
$257.85K
Jonathan David Schwartz
1 Feb 2021
Chief Medical Officer
Exercised, kept
11,428
$1.69
$19.31K
Gaurav Shah
24 Mar 2020
President & CEO
Exercised, kept
90,925
$0.43
$39.10K
Gaurav Shah
25 Feb 2020
President & CEO
Exercised, kept
290,000
$0.43
$125.63K
Kinnari Patel
20 Dec 2018
Chief Operating Officer
Exercised, kept
55,869
$1.21
$67.60K

What was left out

Form 4 filings counted 306
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 18
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 114
Transactions with no price 0
Shares from compensation/vesting 17,342,953
Sales filed before the plan box existed 17
History held since 25 Feb 2015